Antitumor Effect of the KRAS G12C Inhibitor Sotorasib combined with Radiotherapy and Carboplatin/Cisplatin in human Lung Carcinoma Cell Lines

被引：0
|
作者：
Maltzahn, Christin [1 ]
Patties, Ina [1 ]
Kortmann, Rolf-Dieter [1 ]
Seidel, Clemens [1 ]
Glasow, Annegret [1 ]
机构：
[1] Univ Leipzig, Klin & Poliklin Strahlentherapie, Leipzig, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2023年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P10-1
引用
收藏
页码：S101 / S101
页数：1
相关论文
共 50 条
  • [21] A phase 1/2 study of VS-6766 (RAF/MEK clamp) in combination with sotorasib (G12C inhibitor) in patients with KRAS G12C mutant non-small cell lung cancer (NSCLC) (RAMP 203).
    Govindan, Ramaswamy
    Awad, Mark M.
    Gadgeel, Shirish M.
    Pachter, Jonathan A.
    Patrick, Gloria
    Denis, Louis J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [22] KRAS G12C mutations in non-small cell lung cancer
    Li, J. J.
    Wu, X. J.
    Farzin, M.
    Bray, V.
    Williamson, J.
    Pal, A.
    Yip, P. Y.
    Hagelamin, A.
    Ding, P.
    Nindra, U.
    Vinod, S.
    French, B.
    Chua, W.
    Gupta, R.
    Cooper, W. A.
    Wang, B.
    Lee, C. S.
    HISTOPATHOLOGY, 2024, 85 : 25 - 25
  • [23] Synergistic antitumor activity of nab-sirolimus in combination with KRAS inhibitors (KRASis) sotorasib and adagrasib in KRAS G12C NSCLC and bladder cancer xenografts
    Hou, Shihe
    Kwon, Andrew
    Nieva, Jorge
    Desai, Neil
    CANCER RESEARCH, 2023, 83 (07)
  • [24] Selinexor (XPO1 inhibitor) in combination with tepotinib (MET inhibitor) potentially inhibits SHOC2 and KRAS G12C in KRAS G12C mutant non-small cell lung cancer
    Rosell, R.
    Jain, A.
    Codony-Servat, J.
    Shivamallu, C.
    Kollur, S. P.
    Prasad, A.
    Vishwanath, P.
    Jantus Lewintre, E.
    Ito, M.
    Cardona Zorrilla, A. F.
    Arrieta Rodriguez, O. G.
    Pedraz-Valdunciel, C.
    Gonzalez Nieto, J.
    Aguilar, A.
    Molina-Vila, M. A.
    Gonzalez Cao, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S1188 - S1188
  • [25] Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer
    Alessandro Di Federico
    Ilaria Ricciotti
    Valentina Favorito
    Sandra Vietti Michelina
    Pietro Scaparone
    Giulio Metro
    Andrea De Giglio
    Federica Pecci
    Giuseppe Lamberti
    Chiara Ambrogio
    Biagio Ricciuti
    Current Oncology Reports, 2023, 25 : 1017 - 1029
  • [26] CodeBreaK 200: A Phase 3 Multicenter Study of Sotorasib, a KRAS(G12C) Inhibitor, versus Docetaxel in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC) Harboring KRAS p.G12C Mutation
    Reck, M.
    Spira, A.
    Besse, B.
    Wolf, J.
    Skoulidis, F.
    Borghaei, H.
    Goto, K.
    Park, K.
    Griesinger, F.
    Font, E. F.
    Boyer, M.
    Barrios, C. H.
    Goss, G.
    Yang, H.
    Obiozor, C.
    Ramalingam, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S29 - S29
  • [27] Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer
    Di Federico, Alessandro
    Ricciotti, Ilaria
    Favorito, Valentina
    Michelina, Sandra Vietti
    Scaparone, Pietro
    Metro, Giulio
    De Giglio, Andrea
    Pecci, Federica
    Lamberti, Giuseppe
    Ambrogio, Chiara
    Ricciuti, Biagio
    CURRENT ONCOLOGY REPORTS, 2023, 25 (09) : 1017 - 1029
  • [28] Sotorasib, a KRAS-G12C Inhibitor, Induces Chemoresistance by Activating Human Pregnane Xenobiotic Receptor
    Salamat, Julia
    Abbott, Kodye L.
    Ledbetter, Elizabeth L.
    Xu, Chuanling
    Pondugula, Satyanarayana R.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 385
  • [29] Dynamic changes in circulating tumor DNA (ctDNA) in patients treated with sotorasib for KRAS G12C mutant non-small cell lung cancer
    Murciano-Goroff, Yonina R.
    Skoulidis, Ferdinandos
    Velcheti, Vamsidhar
    Falchook, Gerald S.
    Dy, Grace
    Ramalingam, Suresh
    Edelman, Martin J.
    Wolf, Jurgen
    Italiano, Antoine
    Reis-Filho, Jorge S.
    Razavi, Pedram
    Drilon, Alexander
    Misale, Sandra
    Yaeger, Rona
    Li, Mark
    Hindoyan, Antreas
    Ang, Agnes
    Anderson, Abraham A.
    Hong, David
    Lito, Piro
    Govindan, Ramaswamy
    Li, Bob T.
    CANCER RESEARCH, 2023, 83 (07)
  • [30] Lumykras® (Sotorasib) receives EU Approval for Female Patients with KRAS G12C Mutation-positive Non-small Cell Lung Cancer
    Freye, Reimund
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (1-2) : 73 - 73
12345